Barbara C Castelnuovo - Infectious Diseases

Author Information

Barbara Castelnuovo is affiliated with the Infectious Diseases Institute at Makerere University, located in Kampala, Uganda. Her work primarily focuses on infectious diseases, particularly HIV and its associated treatments and complications. Her research contributions have been significant in understanding the dynamics of HIV treatment and prevention in resource-limited settings.

Research Contributions

Barbara Castelnuovo has made significant research contributions in the field of HIV treatment and its associated challenges. Her recent studies explore various aspects of HIV management, including the efficacy and safety of different antiretroviral therapies, the impact of COVID-19 on reducing stigma in African HIV clinics, and the sustainability of mHealth tools for ART adherence. Her work also addresses socioeconomic and healthcare barriers faced by vulnerable populations such as female sex workers in Uganda. These efforts highlight the importance of both medical and social interventions in improving health outcomes for people living with HIV.

Aliases

Throughout her academic career, Barbara Castelnuovo has been referenced under several aliases, including B Castelnuovo, B. Castelnuovo, Barbara C Castelnuovo, and Barbara Castelnuovo.

Publication and Citation Metrics

Metric	Value
Total Papers	222
Total Citation Count	3535
H-Index	33

Publications:

Association between integrase strand transfer inhibitor (INSTIs) use with insulin resistance and incident diabetes mellitus in persons living with HIV: A systematic review and meta-analysis protocol

DOI: 10.1371/journal.pone.0264792

Year: 2022

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

DOI: 10.1016/s2352-3018(22)00092-3

Year: 2022

Willingness to pay for an mHealth anti-retroviral therapy adherence and information tool: Transitioning to sustainability, Call for life randomised study experience in Uganda

DOI: 10.1186/s12911-022-01782-0

Year: 2022

Can COVID-19 changes reduce stigma in African HIV clinics?

DOI: 10.1016/S2352-3018(22)00045-5

Year: 2022

Durability of Second-Line Anti-Retroviral Therapy in a Resource-Limited Setting: An 11-Year Analytical Cohort

DOI: 10.2139/ssrn.4057138

Year: 2022

Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis.

DOI: 10.5588/ijtld.20.0956

Year: 2021

Virologic suppression and associated factors in HIV infected Ugandan female sex workers: a cross-sectional study

DOI: 10.4314/ahs.v21i2.15

Year: 2021

“I Felt Very Small and Embarrassed by the Health Care Provider When I Requested to be Tested for Syphilis”: Barriers and Facilitators of Regular Syphilis and HIV Testing Among Female Sex Workers in Uganda

DOI: 10.21203/rs.3.rs-800413/v1

Year: 2021

Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study

DOI: 10.1186/s12879-021-06370-7

Year: 2021

Factors Associated with Uptake of Contraceptives among HIV Positive Women on Dolutegravir based Anti-Retroviral Treatment at Health Centres of Kampala Capital City Authority. A cross sectional study in Uganda.

DOI: 10.21203/RS.3.RS-404132/V1

Year: 2021

What is the Role of Public Health in Managing Gonorrhea?

What Is the Relationship Between Climate Change and Food Security?

How Does Personalized Medicine Apply to Infectious Diseases?

What are the Symptoms of Viral Infections?

What Are the Challenges in Implementing AI?

What are the Future Directions in Antimicrobial Therapies?

What are Antibiotics?

How Can Education Help in the Prevention of Infectious Diseases?

What are the Symptoms of E. Coli Infection?

What Role Do Metabolic Pathways Play in Antibiotic Resistance?

Partnered Content Networks

Relevant Topics